Clinical Trial Results:
A Phase 3, Randomized, Double-blind, Active-controlled (Enoxaparin 40 mg QD),
Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Apixaban
in Subjects Undergoing Elective Total Knee Replacement Surgery.
And Pharmacogenetics Blood Sample Amendment 01 (Version 2.0, Date 31-Jan-2007)
Revised Protocol 01: Incorporates Amendment 02 dated 18-Apr-2007
Administrative Letter 01, v1.0 dated 07-May-2007
Summary
|
|
EudraCT number |
2006-006896-19 |
Trial protocol |
GB ES NL AT BE FR HU SE IT CZ DK DE |
Global completion date |
30 Jan 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Dec 2016
|
First version publication date |
07 Dec 2016
|
Other versions |
|
Summary report(s) |
CV185-047_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.